Cyproteramide is a bisamide insecticide developed by Japan Ishihara Sangyo Co., Ltd. It has the structure of o-formamidobenzamide. It was listed in 2017 and has been registered and listed in the United States, Canada, Australia, Brazil and other countries.
As a new type of bisamide insecticide, cyproteramide has a wide insecticidal spectrum, low dosage and long lasting effect. It is effective against both order pests and their resistant pests. At the same time, cyproteramide has less impact on mammals, beneficial arthropods, and the environment. With the ban and restriction of neonicotinoid insecticides in some countries and regions, cyproteramide can be used as a substitute for neonicotinoid insecticides in some markets, and it can also be regarded as an important part of chlorantraniliprole. Replenish.
The mechanism of action of cyproteramide is different from other bisamide insecticides, and the market potential in the field of resistant pest control is huge in the future. At present, cyproteramide has been registered and listed in many countries and regions around the world, and the compound patent will expire in 2025.